LONDON, Oct. 28, 2024 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its third quarter 2024 financial results and operational highlights before open of US markets on Tuesday, November 12, 2024.
Management will host a conference call and webcast at 8:30 am EDT/1:30 pm BST to discuss the company’s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call.
A simultaneous audio webcast and replay will be accessible on the events section of Autolus’ website.
Contact:
Olivia Manser
+44 (0) 7780 471568
o.manser@autolus.com
Julia Wilson
+44 (0) 7818 430877
j.wilson@autolus.com
Susan A. Noonan
S.A. Noonan Communications
+1-917-513-5303
susan@sanoonan.com
- Pixalate’s March 2025 Top Grossing Mobile Apps in APAC: ‘SimCity’ Ranked No. 1 on Google Play Store in Japan; ‘OLX’ Led on Apple App Store in India; ‘Sudoku’ Ranked No. 1 on Apple App Store in Singapore - April 21, 2025
- Pixalate’s March 2025 Top Grossing Mobile & CTV Apps in LATAM: ‘ViX’ No. 1 on Roku, Amazon Fire TV & Samsung Smart TV in Mexico; ‘Space shooter’ Leads in Brazil on Google Play Store - April 21, 2025
- Pixalate’s March 2025 Top Grossing Mobile & CTV Apps in EMEA: ‘Block Blast!’ Tops Apple App Store in UK, Germany, Netherlands; ‘Hulu’ Led on Roku in UK - April 21, 2025
